← FDA Drug Approvals (Drugs@FDA)
SODIUM POLYSTYRENE SULFONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2016-02-18
Drug application
- FDA Application #
ANDA206815- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM POLYSTYRENE SULFONATE
- Generic name
- SODIUM POLYSTYRENE SULFONATE
- Active ingredients
- SODIUM POLYSTYRENE SULFONATE
- Dosage form
- POWDER
- Route
- ORAL, RECTAL
- Marketing status
- Prescription
- Sponsor
- CHARTWELL RX
- Manufacturer
- Chartwell RX, LLC
- First approval
- 2016-02-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown